Maolac no longer wants to be thought of as ‘the colostrum company’, but a biotech championing biofunctional proteins from both animal and non-animal sources, CEO Maya Ashkenazi explains.
Read more here.
Maolac no longer wants to be thought of as ‘the colostrum company’, but a biotech championing biofunctional proteins from both animal and non-animal sources, CEO Maya Ashkenazi explains.
Read more here.
![[Rebel Fund in TechCrunch] Prompt engineering startup Vellum.ai raises $5M as demand for generative AI services scales](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
